(Q37880281)

24 August 2017

Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine (English)

1 reference

24 August 2017

0 references

James P Burke

1

1 reference

24 August 2017

Robert J Sanchez

2

1 reference

24 August 2017

Ashish V Joshi

3

1 reference

24 August 2017

Joseph C Cappelleri

4

1 reference

24 August 2017

Mahesh Kulakodlu

5

1 reference

24 August 2017

Rachel Halpern

6

1 reference

24 August 2017

26 May 2011

1 reference

24 August 2017

1 reference

24 August 2017

12

1 reference

24 August 2017

1

1 reference

24 August 2017

14-22

1 reference

Clinical manifestations and diagnosis of fibromyalgia

24 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00470.X

Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00470.X

Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00470.X

Disability and quality of life in patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00470.X

Executive function and decision-making in women with fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00470.X

Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00470.X

Fibromyalgia syndrome: practical strategies for improving diagnosis and patient outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00470.X

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00470.X

A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00470.X

Characteristics and healthcare costs of patients with fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00470.X

Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00470.X

Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00470.X

Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1533-2500.2011.00470.X

10.1111/J.1533-2500.2011.00470.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference